Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy

Name: Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
License: Public Domain

Shanghai Junshi Bioscience Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429740
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.